HIV screening was performed with ARCHITECT HIV Ag/Ab Combo assay™ (ABBOTT®) for the simultaneous qualitative detection of HIV-1 p24 antigen and antibodies to HIV-1 (HIV-1 group M and group O) and HIV-2 and a reactive result (S/CO = 146.5) was obtained. The immunoblot assay- INNO-LIA™ HIV I/II Score (Innogenetics®) was further performed in the same plasma sample. LiRAS™ (Line Reader and Analysis Software) was used for automated interpretation and an indeterminate result was readable (gp41: 3+ and p31: 1+). (DOC 26 kb
Statistical Analysis plan: KIR/HLA and viral control in seroconverters in CAPRISA 004 and CAPRISA050...
Intra-laboratory reproducibility with 11-day cultures. Results after 11-day cultures of PBMC from tw...
Quantification of total IgG, IgM and IgA following SIVMAC251 infection in rhesus macaques (PDF 2059 ...
Phenotypic resistance testing (PhenoSense GT ®): The results indicated that the virus (HIV-1 subtype...
Supplementary file 1: Data for 28,952 HIV screening tests on 24,556 unique patients using the Roche ...
Table S1. Clinical characteristics and baseline immune parameters. Table S2. Repertoire and reactivi...
Fisherâs exact tests for variables associated with spontaneous viral clearance among PWID. Provide...
Figure S1. ROC curve for IGRA according to the risk of infection with TB in HIV-infected patients at...
Figure S1. Validation of shRNA system for the study of HIV-1 replication. (A) Western blot detecting...
Questionnaires The data within additional file 1 contains questionnaires, which were used to collect...
Table S2A. The intra-assay valiability. Table S2B. The inter-assay valiability. Table S2C. Sensitivi...
Characteristics of HIV-positive patients with pneumosepsis with and without readmission. (DOCX 17 kb
Table S1 Study population characteristics of HIV infected patients. (DOCX 14âkb
Figure S1. Recombination pattern of the circulant recombinant forms analyzed in this study. Box repr...
The proportion of persons classified by number of STIs and HIV indicator conditions in the period of...
Statistical Analysis plan: KIR/HLA and viral control in seroconverters in CAPRISA 004 and CAPRISA050...
Intra-laboratory reproducibility with 11-day cultures. Results after 11-day cultures of PBMC from tw...
Quantification of total IgG, IgM and IgA following SIVMAC251 infection in rhesus macaques (PDF 2059 ...
Phenotypic resistance testing (PhenoSense GT ®): The results indicated that the virus (HIV-1 subtype...
Supplementary file 1: Data for 28,952 HIV screening tests on 24,556 unique patients using the Roche ...
Table S1. Clinical characteristics and baseline immune parameters. Table S2. Repertoire and reactivi...
Fisherâs exact tests for variables associated with spontaneous viral clearance among PWID. Provide...
Figure S1. ROC curve for IGRA according to the risk of infection with TB in HIV-infected patients at...
Figure S1. Validation of shRNA system for the study of HIV-1 replication. (A) Western blot detecting...
Questionnaires The data within additional file 1 contains questionnaires, which were used to collect...
Table S2A. The intra-assay valiability. Table S2B. The inter-assay valiability. Table S2C. Sensitivi...
Characteristics of HIV-positive patients with pneumosepsis with and without readmission. (DOCX 17 kb
Table S1 Study population characteristics of HIV infected patients. (DOCX 14âkb
Figure S1. Recombination pattern of the circulant recombinant forms analyzed in this study. Box repr...
The proportion of persons classified by number of STIs and HIV indicator conditions in the period of...
Statistical Analysis plan: KIR/HLA and viral control in seroconverters in CAPRISA 004 and CAPRISA050...
Intra-laboratory reproducibility with 11-day cultures. Results after 11-day cultures of PBMC from tw...
Quantification of total IgG, IgM and IgA following SIVMAC251 infection in rhesus macaques (PDF 2059 ...